Craven LLPrevention of coronary and cerebral thrombosis. Mississippi Valley Med J1956; 78: 213-16.
2.
Weiss HJ, Aledort LM, Kochwa S.The effect of salicylates on the haemostatic properties of platelets in man . J Clin Invest1968; 47: 2169-80.
3.
Harrison Mjg , Meadows J., Ross Russell RW, Marshall J.Effect of aspirin in amaurosis fugax. Lancet1971; ii: 743-44.
4.
Mundall J., Quintero P., von Kaulla KN et al. Transient monocular blindness and increased platelet aggregability treated with aspirin - a case report. Neurology1972; 22: 280-85.
5.
Antiplatelet trialists' collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatmentBr Med J1988; 296: 320-31.
6.
The Canadian cooperative study group.A randomised trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med1978; 299: 53-59.
7.
Anonymous.Aspirin - effective in males threatened with stroke (Editorial). Stroke1978; 9: 295-97.
8.
Harris WH, Salzman EW, Athanasoulis CA et al. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med1977; 297: 1246-49.
9.
Linos A., Worthington JW, O'Fallen W. et al. Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. Mayo Clin Proc1978; 53: 581-86.
10.
Dyken MLAntiplatelet aggregating agents in transient ischemic attacks and the relationship of risk factors. In: Breddin K, Loew D, Uberla K et al. eds, Prophylaxis of venous, peripheral, cardiac and cerebral vascular diseases with acetylsalicylic acid, Stuttgart : F Schattauer Verlag, 1980: 141-48.
11.
Fields WS, Lemak NA, Frankowski RF, Hardy RJControlled trial of aspirin in cerebral ischemia. Stroke1977; 8: 301-16.
12.
Fields WS, Lemak NA, Frankowski RF et al. Controlled trial of aspirin in cerebral ischaemia. Circulation1980; 62: 90-96.
13.
UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J1988; 296: 316-20.
14.
Bousser M-G. , Escwege E., Huguenau M. et al. AICLA controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischaemia . Stroke1983; 14: 5-14.
15.
Sorensen PS, Pedersen H., Marquardsen J. et al. Acetylsalicylic acid and the prevention of stroke in patients with reversible cerebral ischaemic attacks. A Danish cooperative study. Stroke1983; 14: 15-22.
16.
TheESPS Group. The European Stroke Prevention Study (ESPS). Lancet1987; ii: 1351-54.
17.
A Swedish cooperative study.High dose acetylsalicylic acid after cerebral infarction. Stroke1987; 18: 325-34.
18.
Candelise L., Landi G., Perrone P. et al. A randomised trial of aspirin and sulfinpyrazone in patients with TIA stroke1982; 13: 175-79.
19.
Fields WS, Lemak NA, Frankowski RF, Hardy RJControlled trial of aspirin in cerebral ischaemia. Part II: Surgical group . Stroke1978; 9: 309-19.
20.
Kaegi A., Pineo GF, Shimizu A. et al. The role of sulfinpyrazone in the prevention of arteriovenous shunt thrombosis. Circulation1975 ; 52: 497-99.
21.
Johnson M., Ramey E., Ramwell PWAndrogen-mediated sensitivity in platelet aggregationAm J Physiol1977 ; 232: H381-385.
22.
Orchard MA, Botting JHThe influence of sex hormones on rat platelet sensitivity to adenosine-diphosphate . Thromb Haemost1981;46:496-99.
23.
Morikawa M. , Kojima T., Inoue M., Tsuboi M.Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism. JpnJ Pharmacol1985; 37: 317-23.
24.
Vessey MP, Mann JIFemale sex hormones and thrombosisBr Med Bull1978; 34: 157-62.
25.
Poller L.Oral contraceptives, blood clotting and thrombosis. Br Med Bull1978; 34: 151-56.
26.
Elkeles RS, Hampton JR, Mitchell Jra.Effect of oestrogens on human platelet behaviour. Lancet1968; ii: 315-18.
27.
Johnson M., Ramey E., Ramwell PWSex and age differences in human platelet aggregation. Nature1975; 253: 355-57.
28.
Pilo R., Aharony D., Raz A.Testosterone potentiation of lonophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism. Thromb Haemost1981; 46: 538-42.
29.
Harrison Mjg , Weisblatt E.A sex difference in the effect of aspirin on 'spontaneous' platelet aggregation in whole blood. Thromb Haemost1983; 50: 773-74.
30.
Brown P., Harrison Mjg.The role of red blood cells in platelet aggregation in whole blood. Atherosclerosis1988; 71: 261-62.
31.
Weksler B., Kent JL, Rudolph D. et al. Effects of low dose aspirin on platelet function in patients with recent cerebral ischaemia. Stroke1985 ; 16: 5-9.
32.
Kelton JS, Carter CJ, Rosenfeld J. et al. Sex-related differences in the efficacy of acetylsalicylic acid (ASA): the absorption of ASA and its effect on collagen-induced thromboxane B2 generation. Thromb Res1981; 24: 163-68.
33.
De la Cruz JP, Bellido I., Camara S. et al. Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood. Scand J Haematol1986; 36: 394-97.
34.
Escolar G., Bastida E., Garrido M. et al. Sex-related differences in the effects of aspirin on the interaction of platelets with subendothelium. Thromb Res1986; 44: 837-47.
35.
Spranger M. , Aspey BS, Harrison Mjg.Sex difference in antithrombotic effect of aspirin. Stroke1989; 20: 34-37.
36.
Uzunova A., Ramey E., Ramwell PWEffect of testosterone, sex, and age on experimentally induced arterial thrombosis . Nature1976; 261: 712-13.
37.
Gent M., Blakely JA, Easton JD, and the CATS group. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet1989; i: 1215-20.
38.
Kelton JG, Hirsh J., Carter CJ, Buchanan MRSex difference in the antithrombotic effects of aspirin. Blood:1978; 52: 1073-76.